7 Elements of a Successful Biotech Funding Plan
CEOs must accept the reality that the success of their company is largely dependent on segment dynamics, in addition to the technology or their management skills
7 Elements of a Successful Biotech Funding Plan
Published in Life Science Leader, November 2019
Authors: Dr. Ellen Baron and Dr. Oded Ben-Joseph
Abstract:
Life sciences companies seeking to raise capital or form early partnerships with strategic players often make avoidable mistakes based on misconceptions stem- ming from management’s internal perspective or from overlooking segment dynamics and the importance of return on capital to investors. But there are some tips that can increase your probability of a successful transaction.
News
Leaders of Life Sciences – How Leadership Must Evolve As Companies Scale
In this conversation, Stan Glazer, Managing Director at Outcome, shares insights from his extensive experience in the life sciences industry.
Read MoreResources
Outcome Capital Life Science Market Pulse, April 2025
Outcome Capital Life Science Market Pulse April 2025 Click to view our LifeSciences Pulse Newsletter
DownloadContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2025. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC
Business Continuity Plan | Privacy Policy | Regulation Best Interest
